Companies Gearing Up to Provide Ultra-Cold Chain Storage for COVID-19 Vaccine Candidates, an Industrial Info Market Brief

Promising results for Pfizer and Moderna's COVID-19 vaccines have freight transportation and warehousing firms scrambling to construct building infrastructure and portable freezers to distribute the upcoming vaccines. Pfizer's vaccine candidate, with 90% efficacy, requires a storage temperature of -70 degrees Celsius (-94 F), and Moderna's candidate, with 94.5% efficacy, requires -20 degrees Celsius (-4 F).